In the most recent trading session, Tilray Brands, Inc. (TLRY) closed at $10.42, indicating a -6.63% shift from the previous trading day.
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling
NEW YORK and LEAMINGTON, Ontario, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods co
Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories.
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff
President Donald Trump's marijuana reclassification executive order followed a yearlong push by cannabis executives, billionaire allies and political operatives combining donations, lobbying and targe
Tilray Brands' stock performance hinges on the outlook for marijuana reform in the U.S. President Trump is considering rescheduling marijuana, which has investors bullish on Tilray of late. The compan
Investors felt the cannabis executive order didn't go far enough. Tilray's CEO backed President Trump's decision, but called it an "incremental step.
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted t
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal gov
Trump's executive order to move marijuana to Schedule III could reshape cannabis regulation and taxes, lifting sentiment around cannabis stocks.
Rep. Greg Steube, R-Fla., joins ‘Mornings with Maria' to discuss cutting healthcare costs, the fight over Obamacare subsidies and shutdown risks, President Donald Trump's marijuana order and the GOP
Kevin Sabet, Smart Approaches to Marijuana CEO, former White House drug policy advisor and ‘One Nation Under Influence' author, joins 'Squawk Box' to discuss President Trump's executive order to rec
U.S. President Donald Trump's move to relax marijuana regulations could ease some burden for cannabis companies, but will likely keep doors to access capital from big banks closed, experts said.
Trulieve Founder, Chair, and CEO Kim Rivers joins 'Fast Money' with reaction to Pres. Trump reclassifying marijuana.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE